Together, these findings support a model in which IMP3 functions upstream of the SREBP–FASN axis as an mRNA-binding amplifier of lipogenic signaling, promoting lipid accumulation in cervical cancer cells and suggesting a tractable metabolic vulnerability. Here, FASN is linked to cervical cancer.